In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
The new online Learning Center with new content can still be found under the “Training” folder on ...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...